Ropes & Gray Represents Patient Square Capital as Regulatory Counsel in $2.6 Billion Take-Private Acquisition of Premier Inc.

Ropes & Gray advised Patient Square Capital as regulatory counsel in the agreement to acquire Premier, Inc. in a deal valued at $2.6 billion. In connection with the transaction, Premier will suspend the distribution of common stock dividends in future quarters. The transaction was announced on September 22 and is subject to approval by Premier stockholders and regulators.

Under the agreement, which was unanimously approved by Premier’s Board of Directors, Premier stockholders will receive $28.25 in cash per share. Upon completion of the transaction, Premier will be a private company and Premier common stock will no longer be listed or traded on any public exchange.

Patient Square Capital is an investment firm that partners with growth oriented companies whose products, services and technologies improve health.

Premier Inc. is a leading technology-driven health care company that provides data, analytics, consulting and supply chain solutions for health care provides, suppliers, payers and policymakers.

The Ropes & Gray team included health care partners Christina Bergeron and Eve Brunts, and health care associate Gideon Palte.